173 related articles for article (PubMed ID: 10522710)
1. Structure-activity relationship in two series of aminoalkyl substituted coumarin inhibitors of gyrase B.
Laurin P; Ferroud D; Schio L; Klich M; Dupuis-Hamelin C; Mauvais P; Lassaigne P; Bonnefoy A; Musicki B
Bioorg Med Chem Lett; 1999 Oct; 9(19):2875-80. PubMed ID: 10522710
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of coumarincarboxylic acids as inhibitors of gyrase B. L-rhamnose as an effective substitute for L-noviose.
Ferroud D; Collard J; Klich M; Dupuis-Hamelin C; Mauvais P; Lassaigne P; Bonnefoy A; Musicki B
Bioorg Med Chem Lett; 1999 Oct; 9(19):2881-6. PubMed ID: 10522711
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B.
Laurin P; Ferroud D; Klich M; Dupuis-Hamelin C; Mauvais P; Lassaigne P; Bonnefoy A; Musicki B
Bioorg Med Chem Lett; 1999 Jul; 9(14):2079-84. PubMed ID: 10450985
[TBL] [Abstract][Full Text] [Related]
4. Coumarin inhibitors of gyrase B with N-propargyloxy-carbamate as an effective pyrrole bioisostere.
Periers AM; Laurin P; Ferroud D; Haesslein JL; Klich M; Dupuis-Hamelin C; Mauvais P; Lassaigne P; Bonnefoy A; Musicki B
Bioorg Med Chem Lett; 2000 Jan; 10(2):161-5. PubMed ID: 10673102
[TBL] [Abstract][Full Text] [Related]
5. The interaction between coumarin drugs and DNA gyrase.
Maxwell A
Mol Microbiol; 1993 Aug; 9(4):681-6. PubMed ID: 8231802
[TBL] [Abstract][Full Text] [Related]
6. A scintillation proximity assay amenable for screening and characterization of DNA gyrase B subunit inhibitors.
Gevi M; Domenici E
Anal Biochem; 2002 Jan; 300(1):34-9. PubMed ID: 11743689
[TBL] [Abstract][Full Text] [Related]
7. Alteration of Escherichia coli topoisomerase IV to novobiocin resistance.
Hardy CD; Cozzarelli NR
Antimicrob Agents Chemother; 2003 Mar; 47(3):941-7. PubMed ID: 12604525
[TBL] [Abstract][Full Text] [Related]
8. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
Hooper DC; Wolfson JS; McHugh GL; Winters MB; Swartz MN
Antimicrob Agents Chemother; 1982 Oct; 22(4):662-71. PubMed ID: 6295263
[TBL] [Abstract][Full Text] [Related]
9. Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors.
Jakopin Ž; Ilaš J; Barančoková M; Brvar M; Tammela P; Sollner Dolenc M; Tomašič T; Kikelj D
Eur J Med Chem; 2017 Apr; 130():171-184. PubMed ID: 28246042
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.
Nakada N; Gmünder H; Hirata T; Arisawa M
Antimicrob Agents Chemother; 1994 Sep; 38(9):1966-73. PubMed ID: 7811004
[TBL] [Abstract][Full Text] [Related]
11. Design, green one-pot synthesis and molecular docking study of novel N,N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV.
Metwally NH; Abdallah SO; Mohsen MMA
Bioorg Chem; 2020 Apr; 97():103672. PubMed ID: 32145481
[TBL] [Abstract][Full Text] [Related]
12. Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization.
Miller JR; Herberg JT; Tomilo M; McCroskey MC; Feilmeier BJ
Anal Biochem; 2007 Jun; 365(1):132-43. PubMed ID: 17395144
[TBL] [Abstract][Full Text] [Related]
13. A 4.2 kDa synthetic peptide as a potential probe to evaluate the antibacterial activity of coumarin drugs.
Scatigno AC; Garrido SS; Marchetto R
J Pept Sci; 2004 Sep; 10(9):566-77. PubMed ID: 15473264
[TBL] [Abstract][Full Text] [Related]
14. Coumarin-containing hybrids and their antibacterial activities.
Feng D; Zhang A; Yang Y; Yang P
Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900380. PubMed ID: 32253782
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors.
Durcik M; Tammela P; Barančoková M; Tomašič T; Ilaš J; Kikelj D; Zidar N
ChemMedChem; 2018 Jan; 13(2):186-198. PubMed ID: 29206345
[TBL] [Abstract][Full Text] [Related]
16. Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.
Gross CH; Parsons JD; Grossman TH; Charifson PS; Bellon S; Jernee J; Dwyer M; Chambers SP; Markland W; Botfield M; Raybuck SA
Antimicrob Agents Chemother; 2003 Mar; 47(3):1037-46. PubMed ID: 12604539
[TBL] [Abstract][Full Text] [Related]
17. Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I.
Tabary X; Moreau N; Dureuil C; Le Goffic F
Antimicrob Agents Chemother; 1987 Dec; 31(12):1925-8. PubMed ID: 2830840
[TBL] [Abstract][Full Text] [Related]
18. Differential sensitivity of gene expression in vitro to inhibitors of DNA gyrase.
Yang HL; Heller K; Gellert M; Zubay G
Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3304-8. PubMed ID: 226966
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial and DNA gyrase-inhibitory activities of novel clorobiocin derivatives produced by mutasynthesis.
Galm U; Heller S; Shapiro S; Page M; Li SM; Heide L
Antimicrob Agents Chemother; 2004 Apr; 48(4):1307-12. PubMed ID: 15047534
[TBL] [Abstract][Full Text] [Related]
20. Novel coumarin-thiazolyl ester derivatives as potential DNA gyrase Inhibitors: Design, synthesis, and antibacterial activity.
Liu H; Xia DG; Chu ZW; Hu R; Cheng X; Lv XH
Bioorg Chem; 2020 Jul; 100():103907. PubMed ID: 32413631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]